Hälsa & medicin

A new study finds that distance runners disconnecting from smartwatches experience both psychological liberation and unexpected anxiety about losing digital validation. The research exposes a growing tension: fitness technology designed to motivate users may actually undermine autonomous movement and self-trust—raising questions for wearable makers about long-term user wellbeing and market loyalty.EN

Researchers have developed a systems medicine framework to design targeted nanoparticles for metabolic dysfunction-associated steatotic liver disease (MASLD), the world's most common chronic liver condition. The work could accelerate drug development for a disease affecting roughly one-third of the global population, opening a significant market opportunity for therapeutics that prevent progression to cirrhosis.EN

Researchers have developed a technique to watch toxic metals move inside living cells and change their chemical form—without destroying the cells in the process. The breakthrough could accelerate drug development and help regulators assess environmental health risks from metal exposure in industries ranging from manufacturing to medicine.EN

A new critical assessment of a prolonged-release contraceptive containing ethinyl estradiol and dienogest has identified previously overlooked safety concerns, prompting regulatory and clinical scrutiny. The findings could reshape how manufacturers and healthcare systems evaluate existing hormone formulations and inform labeling decisions.EN

A major European trial is evaluating alternative methods to wire-guided surgery for locating breast tumors, which currently require repeat operations in one-fifth of cases. The findings could reshape surgical practice and reduce costs while improving patient experience—critical as breast-conserving surgery becomes the standard treatment approach.EN

A new survey of U.S. women reveals that metastatic breast cancer patients are willing to trade uncertain survival gains for faster symptom improvement—a finding that could reshape how regulators evaluate cancer drugs and how pharma companies design trials. The research suggests progression-free survival may better reflect patient preferences than previously assumed.EN

European researchers are launching a 2,200-patient trial to identify which women undergoing mastectomy face the highest risk of seroma—fluid accumulation that can trigger infections and disfiguring scars. Pinpointing biological markers could enable preventive strategies, reducing costly complications and improving surgical outcomes across Europe's healthcare systems.EN

A reanalysis of a major cancer trial shows that pembrolizumab combined with chemotherapy improves survival outcomes for early-stage triple-negative breast cancer patients regardless of when they enrolled in the study. The finding reinforces the drug's clinical value and may influence treatment guidelines and insurance coverage decisions for this aggressive cancer type.EN

A major clinical trial has identified two gene signatures that may predict which early-stage breast cancer patients will respond to palbociclib, a widely used targeted drug. The finding could help oncologists personalize treatment and avoid unnecessary medication for patients unlikely to benefit—reducing costs and side effects.EN

A new review finds nursing education research faces a critical gap: studies designed with tight scientific controls often fail to reflect how students actually learn on hospital floors. The mismatch threatens the relevance of findings that shape curriculum design and training budgets across healthcare systems worldwide.EN

The Research Institute for Fragrance Materials published a safety assessment of a synthetic fragrance compound used in perfumes and personal care products. The evaluation is part of ongoing industry efforts to ensure cosmetic ingredients meet safety standards before reaching consumers, following growing regulatory scrutiny of fragrance allergens.EN

An international study found that combining trastuzumab deruxtecan, a widely used advanced breast cancer drug, with radiation therapy did not trigger unexpected safety problems. The finding matters because oncologists treating metastatic breast cancer patients need to know whether these two powerful therapies can be given together without serious complications.EN

Only 10.5% of out-of-hospital cardiac arrest patients in Japan received AED treatment, with application strongly linked to daytime incidents, dispatcher guidance, and school settings. The findings expose critical gaps in emergency response systems that could inform policy changes and resource allocation across healthcare networks.EN

New research maps how drone sperm quality fluctuates throughout the year in Argentine regions, giving beekeepers precise timing for artificial insemination programs. The findings enable breeding operations to select superior genetic lines more reliably, potentially improving hive productivity and disease resistance across commercial and hobbyist operations.EN

Researchers at the Research Institute for Fragrance Materials assessed ethyl ricinoleate, a widely used fragrance ingredient, and confirmed it meets safety standards for consumer products. The finding supports continued use of the ingredient in cosmetics and personal care items, adding to a growing body of ingredient-by-ingredient safety data that manufacturers rely on for regulatory compliance.EN

A large prospective study found that artificial intelligence algorithms can score immune activity in triple-negative breast cancers as reliably as pathologists do. The finding could help standardize tumor analysis across hospitals and may enable faster, more consistent treatment decisions for one of cancer's most aggressive forms.EN

A major study found that 16% of hormone-responsive breast cancers change into harder-to-treat forms when they metastasize, with patients experiencing early treatment failure. The discovery could reshape how doctors monitor and treat early-stage breast cancer, potentially opening new markets for diagnostic tests and combination therapies.EN

A major five-year screening trial reveals which recruitment strategies actually work to enroll racially and geographically diverse women in cancer research. The findings matter for trial sponsors and health systems designing studies that reflect real-world populations—and for meeting diversity mandates from regulators and funders.EN

Researchers have developed updated Rome V questionnaires to diagnose disorders of gut-brain interaction—conditions affecting millions worldwide. The new diagnostic framework could improve clinical accuracy and drug development for a market currently underserved by precise diagnostic standards.EN

A major screening trial found that the majority of women who received risk-based mammography recommendations never discussed them with their primary care doctors. The finding raises questions about how health systems can better integrate new screening approaches into routine care—a critical issue as medicine shifts toward personalized risk assessment.EN

Researchers identified specific genetic mutations that cause tumors to resist a three-drug combination designed to overcome treatment resistance in advanced breast cancer. The findings could help oncologists predict which patients will benefit from the expensive triplet therapy and which may need alternative approaches sooner.EN

A major study comparing personalized screening to current guidelines found that tailoring mammography frequency to individual risk profiles could significantly reduce national screening expenses. The finding matters to insurers, health systems, and policymakers weighing whether to shift from one-size-fits-all screening to individualized approaches.EN

A new survey of Black breast cancer survivors identifies specific barriers preventing enrollment in clinical trials, despite rising awareness. The findings matter because Black women face more aggressive disease and worse outcomes—yet remain drastically underrepresented in research that could improve treatments and survival rates.EN

Researchers have developed a digital decision support system to reduce dental anxiety in cancer patients at risk of a serious jaw condition. The finding matters because cancer treatment often requires dental monitoring, yet anxiety-driven avoidance can lead to severe complications—suggesting a scalable way to improve patient compliance and outcomes.EN

Researchers identified isotocyanozene, a dangerous nitazene-class opioid potentially more powerful than fentanyl, in a routine sample at an Australian drug checking service. The discovery signals that these emerging synthetic opioids are spreading beyond Europe and highlights the need for rapid surveillance systems as illegal drug markets evolve faster than public health agencies can monitor.EN